Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 2259374)

Published in BMC Med on January 31, 2008

Authors

J A 'Chris' Delaney1, Verena Schneider-Lindner, Paul Brassard, Samy Suissa

Author Affiliations

1: Division of Clinical Epidemiology, McGill University Health Center, Royal Victoria Hospital, 687 Pine Avenue West, Ross 4,29, Montreal, H3A 1A1, Canada. joseph.delaney@mail.mcgill.ca

Articles cited by this

Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med (2006) 18.83

Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med (2005) 12.75

The UK General Practice Research Database. Lancet (1997) 10.62

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis (2005) 6.85

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet (2006) 6.15

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf (2006) 4.64

Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf (2007) 3.66

Basic methods for sensitivity analysis of biases. Int J Epidemiol (1996) 3.64

Demystifying optimal dynamic treatment regimes. Biometrics (2007) 3.54

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ (2006) 3.18

Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet (2005) 2.99

Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ (2006) 2.56

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ (2006) 2.37

Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis (2005) 2.35

Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages. Nat Clin Pract Rheumatol (2007) 2.18

A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis (2007) 1.74

Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents (2006) 1.52

Bayesian sensitivity analysis for unmeasured confounding in observational studies. Stat Med (2007) 1.44

Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord (2005) 1.34

Impact of missing data due to selective dropouts in cohort studies and clinical trials. Epidemiology (2002) 1.30

Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest (2005) 1.06

Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan. BMC Infect Dis (2007) 1.05

Using generalized additive models to reduce residual confounding. Stat Med (2004) 0.99

Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis (2007) 0.95

Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health (2006) 0.90

Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect (2006) 0.88

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Finland. J Hosp Infect (2004) 0.87

Articles by these authors

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87

Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75

Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med (2007) 6.23

Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ (2013) 5.33

Use of statins and the risk of death in patients with prostate cancer. J Clin Oncol (2013) 5.28

Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med (2011) 4.62

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med (2007) 3.94

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ (2012) 3.82

Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry (2009) 3.33

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ (2006) 3.18

Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA (2013) 3.16

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ (2010) 3.09

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther (2008) 2.87

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology (2008) 2.87

Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65

ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64

The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (2010) 2.40

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation (2006) 2.34

Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis (2006) 2.29

Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ (2007) 2.02

Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01

Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf (2007) 1.98

Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med (2007) 1.96

Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J (2008) 1.94

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ (2008) 1.91

Natural history of multiple sclerosis with childhood onset. N Engl J Med (2007) 1.89

The nested case-control study in cardiology. Am Heart J (2003) 1.84

Arthrography of the shoulder: a simple fluoroscopically guided approach for targeting the rotator cuff interval. AJR Am J Roentgenol (2004) 1.76

Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67

The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67

The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost (2013) 1.53

Men who have sex with men in India: a systematic review of the literature. J LGBT Health Res (2008) 1.51

Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol (2006) 1.49

Atrophy and fatty infiltration of the supraspinatus muscle: sonography versus MRI. AJR Am J Roentgenol (2008) 1.49

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr (2004) 1.48

The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol (2004) 1.44

Use of lithium and the risk of injurious motor vehicle crash in elderly adults: case-control study nested within a cohort. BMJ (2004) 1.44

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis (2012) 1.43

The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care (2012) 1.42

Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40

Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months. Am J Respir Crit Care Med (2004) 1.40

Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev (2010) 1.39

Antibiotics in primary prevention of stroke in the elderly. Stroke (2003) 1.39

Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke (2006) 1.38

Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol (2011) 1.37

Point: were industry-sponsored roflumilast trials appropriate? Yes. Chest (2014) 1.36

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32

MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain (2004) 1.31

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. BMJ (2014) 1.27

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24

Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol (2008) 1.23

Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med (2013) 1.22

The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res (2008) 1.21

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21

Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol (2007) 1.20

Dynamic sonography evaluation of shoulder impingement syndrome. AJR Am J Roentgenol (2006) 1.20

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf (2009) 1.19

Epidemiology of Crohn's disease in Québec, Canada. Inflamm Bowel Dis (2009) 1.19

The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Public Health (2006) 1.18

Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev (2008) 1.14

Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol (2013) 1.13

Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord (2007) 1.12

Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med (2010) 1.12

Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum (2009) 1.10

Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls. BMC Public Health (2011) 1.09

Re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16. Eur Urol (2013) 1.09

Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med (2008) 1.09

Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother (2010) 1.08

Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol (2002) 1.06

Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis (2007) 1.06

Molecular epidemiology of tuberculosis in Montreal. CMAJ (2002) 1.06

Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting. J Clin Microbiol (2003) 1.06

Dwellings, crowding, and tuberculosis in Montreal. Soc Sci Med (2006) 1.05

The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04

Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol (2008) 1.02

Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain (2007) 1.01

Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis (2009) 1.00

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol (2005) 1.00

Warfarin use and the risk of motor vehicle crash in older drivers. Br J Clin Pharmacol (2006) 1.00

Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes (2003) 0.99

Genomic characterization of an endemic Mycobacterium tuberculosis strain: evolutionary and epidemiologic implications. J Clin Microbiol (2004) 0.99

Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol (2006) 0.98

Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation (2010) 0.98

Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf (2008) 0.98

An Algorithm for Systemic Inflammatory Response Syndrome Criteria-Based Prediction of Sepsis in a Polytrauma Cohort. Crit Care Med (2016) 0.98

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment. Arthritis Res Ther (2010) 0.97

Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum (2009) 0.96

Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflamm Bowel Dis (2014) 0.96

Simvastatin in moderate-to-severe COPD. N Engl J Med (2014) 0.96

The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology (2006) 0.96

Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis (2007) 0.95

Long-term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiol Drug Saf (2008) 0.95